Composition
- Active ingredients
- COPANLISIB DIHYDROCHLORIDE 60MG/VIAL
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA209936.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Aliqopa
- Active substance
- copanlisib dihydrochloride
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- Bayer Healthcare
- Status
- Discontinued
- FDA approval
- 14 Sept 2017
- Application
- NDA209936-001